GcMAF Cancer - Maria Trading

GcMAF Cancer

GcMAF (or Gc protein – derived macrophage activating factor) is a protein produced by modification of vitamin D – binding protein. GcMAF has not been properly studied in clinical trials and its laboratory results still need to be confirmed independently. So far, all claims on the efficacy of this product have no solid scientific basis. Its marketing is illegal; therefore there is no controlled guarantee on the quality of the product for human consumption sold over the internet.

  • The best results will be obtained from 2nd Generation GcMAF injection in combination with Oral Colostrum GcMAF (capsules, spray or candy) and if possible, with Tumor Treating Fields Electrical cancer therapy.
  • In general, GcMAF injection is conducted by subcutaneous or intramuscular administration, near the tumors, if possible.
  • Oral colostrum GcMAF is effective for patients with low nutrition and cancer cachexia by improving appetite, increasing energy and alleviating fatigue.
  • Oral colostrum GcMAF is usually taken by oral administration. For example, 20 minutes before breakfast in the morning and before bed time.



For Adult
4 capsules / day, 2 capsules in the morning 20 minutes before breakfast and 2 capsules before bed time.
For child ( 20 kg )
2 capsules / day, 1 capsule in the morning 20 minutes before breakfast and 1 capsule before bed time.
For cancer cachexia
6 – 8 capsules / day, 2 capsules 3 – 4 times before meal.